Description
Cilostazolisaquinoloneinhibitorofphosphodiesterase3B(PDE3B)thatexhibitsvasodilatory,antiplatelet,anti-inflammatory,anti-diabetic,antidepressant,anxiolytic,andpro-angiogenicactivities.Cilostazolisclinicallyusedtotreatintermittentclaudicationassociatedwithperipheralvasculardisease.CilostazoldecreasesproductionofTNF-αinmacrophagesandinhibitsTNF-α-inducedinflammationinADIposetissue,improvingglucosetoleranceandinsulinresistanceinvivo.Additionally,cilostazoldecreasesimmobilitytimeintheforcedswimtestandburyingactivityinthemarbleburyingtest.Inotheranimalmodels,thiscompoundupregulatesproductionofG-CSFandVEGF,inducingangiogenesis.